Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
12/2007
12/12/2007CN100354278C Quinazoline derivatives as SRC tyrosine kinase inhibitors
12/06/2007WO2007138974A1 Novel heterocyclic compound or salt thereof and intermediate thereof
12/06/2007WO2007061737A3 FUSED BICYCLIC mTOR INHIBITORS
12/06/2007CA2652501A1 Novel heterocyclic compound or salt thereof and intermediate thereof
12/04/2007US7304072 Spiro compounds
12/04/2007CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007CA2241495C N,n',n'''-tris{2,4-bis[(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)alkylamino]-s-triazin-6-yl}-3,3'-ethylenediiminodipropylamines, their isomers and bridged derivatives and polymer compositions stabilized therewith
11/2007
11/29/2007WO2007136982A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275959 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
11/29/2007CA2652840A1 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases
11/29/2007CA2651690A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/29/2007CA2647830A1 Central nervous system active fused bicycloheterocycle substituted azabicyclic alkane derivatives
11/28/2007EP1858902A1 Bicyclic heteroaromatic derivatives useful as anticancer agents
11/28/2007EP1006794B1 A method for treating or preventing alzheimer's disease
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007US7301012 Azo dye, image-forming coloring composition, ink for ink jet recording, heat-sensitive recording material, color toner and color filter
11/27/2007US7300927 Method for treating or preventing Alzheimer's disease
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1281711B1 Interstrand crosslinking agents for dna and compounds therefor
11/21/2007CN101074233A 4'-demethylpodoph-yllotoxin derivative, its production and use
11/21/2007CN100349898C Podophyllotoxin derivatives and their preparing method
11/20/2007US7297734 Preparation of polyalkyl-1-oxadiazaspirodecanones compounds (e.g., 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodispiro[5.1.11.2]heneicosane hydrochloride) by reacting epihalohydrin with an oxadiazaspirodecanone using a phase transfer catalyst and polymerizing the product
11/20/2007US7297705 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
11/20/2007US7297695 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/15/2007WO2007131020A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007WO2007130860A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007US20070265295 1-Heterocyclyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones
11/15/2007US20070265193 Tetraazabenzo[e]azulene derivatives and analogs thereof
11/15/2007CA2651033A1 Constrained compounds as cgrp-receptor antagonists
11/14/2007EP1853604A2 Chemical compounds
11/08/2007WO2007127635A2 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007WO2007127183A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007CA2650382A1 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007CA2650295A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007CA2650290A1 Pharmaceutical compounds
11/07/2007CN100347176C Novel dithiolopyrrolones with therapeutic activity
11/07/2007CN100347173C Pyrazoloquinolines with immunomodulating activity
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291612 Immunomodulatory compounds
11/01/2007WO2007121924A2 Bisadenosine compounds as adenosine a2a receptor agonists
11/01/2007US20070254937 Thienopyrazoles
11/01/2007CA2648037A1 Organic compounds
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007CN100345853C Pyrazolopyrimidine compound and method for producing the same
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007CA2288703C Phthalocyanine and use of phthalocyanine as a marking agent
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1846419A2 Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
10/24/2007EP1846418A2 Antibacterial agents
10/24/2007EP1846417A1 Antibacterial agents
10/24/2007EP1845995A1 Antibacterial agents
10/23/2007US7285556 Antiproliferative agents; hematologic, nervous system, autoimmune diseases; osteoporosis, viral infections
10/23/2007US7285550 Triazolotriazines and pyrazolotriazines and methods of making and using the same
10/23/2007CA2350905C Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
10/18/2007WO2007115999A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/18/2007US20070244148 Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment
10/18/2007US20070244090 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
10/18/2007CA2648170A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/11/2007WO2007113290A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
10/11/2007WO2007113226A1 Organic compounds
10/11/2007WO2006108948A3 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238747 Rifamycin analogs and uses thereof
10/11/2007CA2646090A1 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
10/11/2007CA2644963A1 Organic compounds
10/10/2007EP1558252B1 Substituted furo [2,3-b]pyridine derivatives
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007CN101052642A Novel double-azaindole derivatives, their preparation and medicinal application thereof as kinase inhibitors
10/10/2007CN101050221A Derivative of thiophene for producing organic ligand of electric or luminous polymer, and preparation method
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN100341876C Spiro-substituted pyrrolopyrimidines
10/09/2007US7279575 Such as 2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrochloride; for treatment of cell proliferative disorders/cancer; kits
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/04/2007WO2007093365A3 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
10/04/2007US20070232812 optical, electro-optical, electronic devices liquid crystal displays, optical films, organic field effect transistors; integrated circuits
10/04/2007US20070232600 Anti-migraine treatments
10/04/2007US20070227590 Supramolecular Complex of Pyridylnaphthalenediimide with Zinc Porphyrin Dendrimer Having Multiplicity of Artificial Photosynthetic Reaction Center
10/03/2007EP1838718A1 Pyrrolopyrazoles, potent kinase inhibitors
10/03/2007EP1751157B1 Inhibitors of the hiv integrase enzyme
10/02/2007US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
10/02/2007US7276505 Immunomodulating heterocyclic compounds
10/02/2007US7276504 Nasally administering an imidazotriazinone substituted with an (alkoxy)(aminosulfonyl)phenyl group for treating diseases including psoriasis, female infertility, diabetes, glaucoma, cystic fibrosis, pre-eclampsia, Parkinsonism, tinnitus, pain, gastric motility disorders, and pulmonary hypertension
09/2007
09/27/2007WO2007108750A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors
09/27/2007WO2007084557A3 Azaindoles useful as inhibitors of janus kinases
09/27/2007US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/26/2007EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 111